Oxygen uptake rates and liver-specific functions of hepatocyte and 3T3 fibroblast co-cultures

被引:78
作者
Cho, Cheul H.
Park, Jaesung
Nagrath, Deepak
Tilles, Arno W.
Berthiaume, Francois
Toner, Mehmet
Yarmush, Martin L. [1 ]
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA
[3] Shriners Hosp Children, Boston, MA 02114 USA
关键词
oxygen uptake rate; hepatocyte; co-culture; seeding density; mathematical modeling;
D O I
10.1002/bit.21225
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Bioartificial liver (BAL) devices have been developed to treat patients undergoing acute liver failure. One of the most important parameters to consider in designing these devices is the oxygen consumption rate of the seeded hepatocytes which are known to have oxygen consumption rates 10 times higher than most other cell types. Hepatocytes in various culture configurations have been tested in BAL devices including those formats that involve co-culture of hepatocytes with other cell types. In this study, we investigated, for the first time, oxygen uptake rates (OUR)s of hepatocytes co-cultured with 3T3-J2 fibroblasts at various hepatocyte to fibroblast seeding ratios. OURs were determined by measuring the rate of oxygen disappearance using a ruthenium-coated optical probe after closing and sealing the culture dish. Albumin and urea production rates were measured to assess hepatocyte function. Lower hepatocyte density co-cultures demonstrated significantly higher OURs (2 to 3.5-fold) and liver-specific functions (1.6-fold for albumin and 4.5-fold for urea production) on a per cell basis than those seeded at higher densities. Increases in OUR correlated well with increased liver-specific functions. OURs (V-m) were modeled by fitting Michaelis-Menten kinetics and the model predictions closely correlated with the experimental data. This study provides useful information for predicting BAL design parameters that will avoid oxygen limitations, as well as maximize metabolic functions.
引用
收藏
页码:188 / 199
页数:12
相关论文
共 48 条
  • [1] Oxygen Consumption Characteristics of Porcine Hepatocytes
    Balis, Ulysses J.
    Behnia, Kamelia
    Dwarakanath, Bharath
    Bhatia, Sangeeta N.
    Sullivan, Susan J.
    Yarmush, Martin L.
    Toner, Mehmet
    [J]. METABOLIC ENGINEERING, 1999, 1 (01) : 49 - 62
  • [2] Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: Hepatocytes cultured in a sandwich configuration
    Berthiaume, F
    Moghe, PV
    Toner, M
    Yarmush, ML
    [J]. FASEB JOURNAL, 1996, 10 (13) : 1471 - 1484
  • [3] Bhatia S. N., 1996, Cell Eng, V1, P125
  • [4] Microfabrication of hepatocyte/fibroblast co-cultures: Role of homotypic cell interactions
    Bhatia, SN
    Balis, UJ
    Yarmush, ML
    Toner, M
    [J]. BIOTECHNOLOGY PROGRESS, 1998, 14 (03) : 378 - 387
  • [5] Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells
    Bhatia, SN
    Balis, UJ
    Yarmush, ML
    Toner, M
    [J]. FASEB JOURNAL, 1999, 13 (14) : 1883 - 1900
  • [6] Mass transfer limitations to the performance of membrane bioartificial liver support devices
    Catapano, G
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1996, 19 (01) : 18 - 35
  • [7] The coculture: A system for studying the regulation of liver differentiation/proliferation activity and its control
    Corlu, A
    Ilyin, G
    Cariou, S
    Lamy, I
    Loyer, P
    GuguenGuillouzo, C
    [J]. CELL BIOLOGY AND TOXICOLOGY, 1997, 13 (4-5) : 235 - 242
  • [8] Custer L, 1998, ADV EXP MED BIOL, V454, P261
  • [9] A novel full-scale flat membrane bioreactor utilizing porcine hepatocytes: Cell viability and tissue-specific functions
    De Bartolo, L
    Jarosch-Von Schweder, G
    Haverich, A
    Bader, A
    [J]. BIOTECHNOLOGY PROGRESS, 2000, 16 (01) : 102 - 108
  • [10] Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure
    Demetriou, AA
    Brown, RS
    Busuttil, RW
    Fair, J
    McGuire, BM
    Rosenthal, P
    Esch, JSA
    Lerut, J
    Nyberg, SL
    Salizzoni, M
    Fagan, EA
    de Hemptinne, B
    Broelsch, CE
    Muraca, M
    Salmeron, JM
    Rabkin, JM
    Metselaar, HJ
    Pratt, D
    De La Mata, M
    McChesney, LP
    Everson, GT
    Lavin, PT
    Stevens, AC
    Pitkin, Z
    Solomon, BA
    [J]. ANNALS OF SURGERY, 2004, 239 (05) : 660 - 667